http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Zentalis Pharmaceuticals Announces Late-Breaker Oral Presentation on WEE1 Inhibitor, ZN-c3, at the AACR Annual Meeting 2021
-
Zentalis Pharmaceuticals (ZNTL) and Tempus Announce Strategic Collaboration to Advance Research and Development Capabilities
-
Zentalis Pharmaceuticals and Tempus Announce Strategic Collaboration to Advance Research and Development Capabilities
-
Zentalis Pharmaceuticals to Present Initial Clinical Data on ZN-c3 at the AACR Annual Meeting 2021
-
Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors
-
Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials
-
Zentalis Pharmaceuticals to Participate In Two Upcoming Investor Conferences
-
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
-
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
-
Zentalis Pharmaceuticals to Host a Key Opinion Leader Virtual Meeting to Discuss its Investigational WEE1 Inhibitor ZN-c3 and its Potential as a Best-in-Class Treatment for Advanced Solid Tumors
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
Zentalis Pharmaceuticals Appoints Alexis Pinto as Chief Legal Officer
-
Zentalis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Update
-
Zentalis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Update
